Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MTVA
MTVA logo

MTVA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy MetaVia Inc (MTVA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.580
1 Day change
4.64%
52 Week Range
19.030
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

MTVA is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is weak technically, there is no supportive news or catalyst, no bullish proprietary signal, and there is no financial snapshot to justify a long-term entry. Given the current setup and the user’s impatience, I would not buy it now.

Technical Analysis

The technical trend is bearish. MACD histogram is negative at -0.0391 and still contracting, which shows momentum remains weak. RSI_6 at 35.725 is near oversold but not enough to confirm a reversal. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, confirming a downtrend. Price at 1.38 is below the pivot 1.533 and also below S1 1.407, which keeps the chart under pressure. The short-term pattern data suggests a possible modest rebound, but the overall setup is still weak and not a strong entry for a long-term beginner.

Positive Catalysts

  • No news in the recent week, so there are no clear event-driven catalysts. Sentiment from trading trends is neutral, and the stock has no recent bullish insider or hedge fund activity. The only mildly positive item is the pattern-based projection showing a potential upside over the next week and month, but this is not strong enough to override the weak chart.

Neutral/Negative Catalysts

  • There are no recent news catalysts, which removes any immediate momentum driver. Hedge funds are neutral and insiders are neutral, showing no supportive accumulation. The stock is trading in a bearish moving-average structure, MACD is negative, and price is below key support/pivot levels. Post-market change of -6.71% also shows weakness after the session.

Financial Performance

No usable financial snapshot is available because the data returned an error, so the latest quarter season and growth trends cannot be assessed. Based on the provided dataset, there is not enough financial evidence to support a long-term buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible Wall Street upgrade/downgrade trend to support a buy case. Overall, Wall Street pros would likely lean cautious here because there is no news support, no bullish signal, and the chart remains in a downtrend. There is no evidence of recent influential buying or selling activity, and there is no recent congress trading data available.

Wall Street analysts forecast MTVA stock price to rise
2 Analyst Rating
Wall Street analysts forecast MTVA stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.510
sliders
Low
40
Averages
47.5
High
55
Current: 1.510
sliders
Low
40
Averages
47.5
High
55
H.C. Wainwright
Andrew Fein
initiated
$12
AI Analysis
2025-09-04
Reason
H.C. Wainwright
Andrew Fein
Price Target
$12
AI Analysis
2025-09-04
initiated
Reason
H.C. Wainwright analyst Andrew Fein assumed coverage of MetaVia with a Buy rating and $12 price target. The firm says Metavia offers a \"compelling opportunity\" in the metabolic disease space based on its two \"differentiated\" pipeline programs.

People Also Watch